A systematic analysis of the resistance and sensitivity of HER2<sup>YVMA</sup>receptor tyrosine kinase mutant to tyrosine kinase inhibitors in HER2-positive lung cancer
Xiaokun Shen(Convalife (China)), Xiaobing Chen(Sun Yat-sen University), Yuzhou Zhao(Capital Medical University), Tiejun Yang(University of Pittsburgh), Ji‐Cheng Li(Henan University), Beibei Chen(Shandong University of Traditional Chinese Medicine), Feilin Cao(Wenzhou Medical University), Jianjun Qin(Zhengzhou University), Zhaosheng Ma(Wenzhou Medical University), Xinguang Cao(Zhengzhou University), Bojian Xie(Wenzhou Medical University)
Cited by 10
Related Papers
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2019|324
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|168
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140